Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

All the Guidance They Need: Biosimilars Business Development Doesn't Wait For FDA

Jan 15 2012

• By Michael McCaughan

Related Content

Biogen Tests Biosimilars Waters In Joint Venture With Samsung

Dec 12 2011

FDA's Biosimilar Strategy Will Rely On "Fingerprint" Technology To Limit Trials

Aug 04 2011

Related Companies

Amgen, Inc.

Allergan plc

Baxter International Inc.

Momenta Pharmaceuticals, Inc.

Biogen, Inc.

Samsung Bioepis Co., Ltd.

Teva Pharmaceutical Industries Ltd.

Additional Topics

Drug Approval Standards BioPharmaceutical

More from Approval Standards

More from Pathways & Standards

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window